SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024531
Filing Date
2022-11-10
Accepted
2022-11-10 16:33:24
Documents
59
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sprb-20220930.htm   iXBRL 10-Q 2840650
2 EX-31.1 sprb-ex31_1.htm EX-31.1 21899
3 EX-31.2 sprb-ex31_2.htm EX-31.2 20186
4 EX-32.1 sprb-ex32_1.htm EX-32.1 10832
5 EX-32.2 sprb-ex32_2.htm EX-32.2 11015
  Complete submission text file 0000950170-22-024531.txt   8225875

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sprb-20220930_def.xml EX-101.DEF 150313
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sprb-20220930.xsd EX-101.SCH 46455
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sprb-20220930_cal.xml EX-101.CAL 41177
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sprb-20220930_pre.xml EX-101.PRE 286518
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sprb-20220930_lab.xml EX-101.LAB 416950
53 EXTRACTED XBRL INSTANCE DOCUMENT sprb-20220930_htm.xml XML 1334698
Mailing Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104
Business Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104 (415) 294-1687
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

IRS No.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39594 | Film No.: 221377860
SIC: 2834 Pharmaceutical Preparations